Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday, February ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Despite the beat, however ...

Humana depends more than other insurers on revenue from Medicare Advantage, private versions of the government’s program for ...

These five sites are in various stages of redevelopment. The wrecking ball is swinging on two sites, home construction is ...

Oil prices were extending gains from the previous trading session despite fears that President Trump's trade tariffs might ...

These developments underscore a tumultuous period for UnitedHealth Group and Optum, as they navigate cybersecurity threats, ...

Trump’s attack is sinister and reactionary. He is again taking pages from Adolf Hitler’s playbook, attempting to whip up his fascist base with claims about “degenerate art.” ...

We recently compiled a list of the 10 Best Dow Jones Dividend Stocks According to Wall Street Analysts. In this article, we ...

In a report released today, David S Macdonald from Truist Financial maintained a Buy rating on Encompass Health (EHC – Research Report). The ...

In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on The Ensign Group (ENSG – Research Report), with a price ...